NO20013371L - Ekspresjon og eksport av anti-fedmeproteiner som Fc- fusjonsproteiner - Google Patents
Ekspresjon og eksport av anti-fedmeproteiner som Fc- fusjonsproteinerInfo
- Publication number
- NO20013371L NO20013371L NO20013371A NO20013371A NO20013371L NO 20013371 L NO20013371 L NO 20013371L NO 20013371 A NO20013371 A NO 20013371A NO 20013371 A NO20013371 A NO 20013371A NO 20013371 L NO20013371 L NO 20013371L
- Authority
- NO
- Norway
- Prior art keywords
- proteins
- fusion proteins
- nucleotide sequences
- export
- expression
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Child & Adolescent Psychology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Endocrinology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Plant Pathology (AREA)
- Diabetes (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11507999P | 1999-01-07 | 1999-01-07 | |
PCT/US2000/000352 WO2000040615A2 (en) | 1999-01-07 | 2000-01-07 | EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20013371D0 NO20013371D0 (no) | 2001-07-06 |
NO20013371L true NO20013371L (no) | 2001-09-04 |
Family
ID=22359200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20013371A NO20013371L (no) | 1999-01-07 | 2001-07-06 | Ekspresjon og eksport av anti-fedmeproteiner som Fc- fusjonsproteiner |
Country Status (16)
Country | Link |
---|---|
US (1) | US20040053366A1 (es) |
EP (1) | EP1141013A2 (es) |
JP (1) | JP2002534962A (es) |
KR (1) | KR20020007287A (es) |
CN (1) | CN1341121A (es) |
AU (1) | AU778939B2 (es) |
BR (1) | BR0007414A (es) |
CA (1) | CA2356401A1 (es) |
CZ (1) | CZ20012406A3 (es) |
HU (1) | HUP0105090A2 (es) |
ID (1) | ID30327A (es) |
MX (1) | MXPA01006922A (es) |
NO (1) | NO20013371L (es) |
SK (1) | SK9432001A3 (es) |
WO (1) | WO2000040615A2 (es) |
ZA (1) | ZA200105352B (es) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2221717T3 (es) | 1997-12-08 | 2005-01-01 | Emd Lexigen Research Center Corp. | Proteinas de fusion heterodimeras utiles para inmunoterapia dirigida e inmunoestimulacion general. |
US20030105294A1 (en) * | 1998-02-25 | 2003-06-05 | Stephen Gillies | Enhancing the circulating half life of antibody-based fusion proteins |
RU2229305C2 (ru) * | 1998-04-15 | 2004-05-27 | Лексиген Фармасьютикэлс Корпорейшн | Усиление иммунных ответов, опосредованных белками, слитыми из антитела и цитокина, посредством совместного введения ингибитора ангиогенеза |
SK782002A3 (en) * | 1999-07-21 | 2003-08-05 | Lexigen Pharm Corp | FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
HUP0202442A3 (en) * | 1999-08-09 | 2005-01-28 | Lexigen Pharmaceuticals Corp L | Multiple cytokine-antibody complexes |
US20050202538A1 (en) * | 1999-11-12 | 2005-09-15 | Merck Patent Gmbh | Fc-erythropoietin fusion protein with improved pharmacokinetics |
ES2269366T3 (es) | 2000-02-11 | 2007-04-01 | Merck Patent Gmbh | Mejoramiento de la vida media en circulacion de proteinas de fusion basadas en anticuerpos. |
AU7172901A (en) * | 2000-06-29 | 2002-01-14 | Lexigen Pharm Corp | Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
HUP0303171A2 (hu) * | 2001-02-19 | 2003-12-29 | Merck Patent Gmbh | Csökkentett immunogenitású mesterséges fehérjék |
PL362414A1 (en) | 2001-02-19 | 2004-11-02 | Merck Patent Gmbh | Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity |
DK1366067T3 (da) * | 2001-03-07 | 2012-10-22 | Merck Patent Gmbh | Ekspressionsteknologi for proteiner indeholdende en hybrid isotype-antistof-enhed |
WO2002079415A2 (en) * | 2001-03-30 | 2002-10-10 | Lexigen Pharmaceuticals Corp. | Reducing the immunogenicity of fusion proteins |
RU2306320C9 (ru) * | 2001-05-03 | 2008-01-27 | Мерк Патент Гмбх | Рекомбинантное опухолеспецифичное антитело (варианты) и его применение |
RU2312677C9 (ru) * | 2001-12-04 | 2008-03-27 | Мерк Патент Гмбх | Иммуноцитокины с модулированной селективностью |
DK1572748T3 (da) * | 2002-12-17 | 2010-08-23 | Merck Patent Gmbh | Humaniseret antistof (H14.18) af muse-14.18-antistof der binder til GD2 og dets fusionsprotein med IL-2 |
US20050069521A1 (en) * | 2003-08-28 | 2005-03-31 | Emd Lexigen Research Center Corp. | Enhancing the circulating half-life of interleukin-2 proteins |
WO2005047327A2 (en) | 2003-11-12 | 2005-05-26 | Biogen Idec Ma Inc. | NEONATAL Fc RECEPTOR (FcRn)-BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO |
US8846874B2 (en) | 2003-11-13 | 2014-09-30 | Hanmi Science Co., Ltd | IgG Fc fragment for a drug carrier and method for the preparation thereof |
US8110665B2 (en) | 2003-11-13 | 2012-02-07 | Hanmi Holdings Co., Ltd. | Pharmaceutical composition comprising an immunoglobulin FC region as a carrier |
CN100467488C (zh) * | 2003-12-30 | 2009-03-11 | 默克专利有限公司 | Il-7融合蛋白 |
KR20060124656A (ko) * | 2003-12-31 | 2006-12-05 | 메르크 파텐트 게엠베하 | 개선된 약물동태를 가지는 Fc-에리스로포이에틴 융합단백질 |
US8420087B2 (en) | 2004-01-05 | 2013-04-16 | Antisoma Research Limited | Interleukin-12 targeted to oncofoetal fibronectin |
CA2553883C (en) | 2004-01-22 | 2013-04-02 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Anti-cancer antibodies with reduced complement fixation |
US7670595B2 (en) * | 2004-06-28 | 2010-03-02 | Merck Patent Gmbh | Fc-interferon-beta fusion proteins |
JP4937132B2 (ja) * | 2004-12-09 | 2012-05-23 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 免疫原性の低下したil−7変種 |
SG173313A1 (en) | 2005-01-05 | 2011-08-29 | Biogen Idec Inc | Cripto binding molecules |
US7566456B2 (en) * | 2005-06-23 | 2009-07-28 | Haiming Chen | Allergen vaccine proteins for the treatment and prevention of allergic diseases |
KR20080050576A (ko) * | 2005-07-29 | 2008-06-09 | 앰프로틴 코포레이션 | 키메릭 치료제 |
US8227408B2 (en) * | 2005-09-07 | 2012-07-24 | Neurotez, Inc. | Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology |
US20070104689A1 (en) * | 2005-09-27 | 2007-05-10 | Merck Patent Gmbh | Compositions and methods for treating tumors presenting survivin antigens |
EP1801121A1 (en) * | 2005-12-23 | 2007-06-27 | CONARIS research institute AG | Soluble gp130 molecule variants useful as a medicament |
JP5175214B2 (ja) | 2005-12-30 | 2013-04-03 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 改良された安定性を有するインターロイキン−12p40変種 |
JP2009521912A (ja) | 2005-12-30 | 2009-06-11 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 低減された免疫原性を有する抗cd19抗体 |
US7846434B2 (en) | 2006-10-24 | 2010-12-07 | Trubion Pharmaceuticals, Inc. | Materials and methods for improved immunoglycoproteins |
US20080227669A1 (en) * | 2007-03-12 | 2008-09-18 | Halliburton Energy Services, Inc. | Corrosion-inhibiting additives, treatment fluids, and associated methods |
KR20110028457A (ko) | 2008-05-21 | 2011-03-18 | 뉴로테즈 인코포레이티드 | 신경섬유 매듭과 연관된 신경변성 장애를 치료하는 방법 |
AU2009313562B2 (en) | 2008-11-04 | 2012-11-15 | Neurotez, Inc. | Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta |
EP2421896A1 (en) | 2009-04-22 | 2012-02-29 | Merck Patent GmbH | Antibody fusion proteins with modified fcrn binding sites |
WO2012138919A2 (en) | 2011-04-08 | 2012-10-11 | Amgen Inc. | Method of treating or ameliorating metabolic disorders using growth differentiation factor 15 (gdf-15) |
EP3626739A1 (en) | 2011-06-24 | 2020-03-25 | Stephen D. Gillies | Light chain immunoglobulin fusion proteins and methods of use thereof |
BR112014018575A2 (pt) | 2012-01-26 | 2017-07-04 | Amgen Inc | polipetídeos de fator de diferenciação de crescimento 15 (gdf-15) |
WO2014020056A1 (en) | 2012-08-02 | 2014-02-06 | F. Hoffmann-La Roche Ag | METHOD FOR PRODUCING SOLUBLE FcR AS Fc-FUSION WITH INERT IMMUNOGLOBULIN Fc-REGION AND USES THEREOF |
SG11201408530YA (en) * | 2012-08-02 | 2015-03-30 | Hoffmann La Roche | Method for producing monomeric and multimeric molecules and uses thereof |
SG11201500682WA (en) * | 2012-09-07 | 2015-02-27 | Sanofi Sa | Fusion proteins for treating a metabolic syndrome |
PL3027642T3 (pl) | 2013-07-31 | 2021-01-11 | Amgen Inc. | Konstrukty czynnika różnicowania wzrostu 15 (GDF-15) |
GB201403775D0 (en) | 2014-03-04 | 2014-04-16 | Kymab Ltd | Antibodies, uses & methods |
EP3433264A4 (en) | 2016-03-21 | 2019-08-28 | Children's Medical Center Corporation | COMPOSITIONS AND METHODS FOR INHIBITING WNT SIGNALING |
US9567399B1 (en) | 2016-06-20 | 2017-02-14 | Kymab Limited | Antibodies and immunocytokines |
EP3481413A4 (en) * | 2016-07-08 | 2020-01-08 | Askgene Pharma, Inc. | FUSION PROTEIN WITH LEPTIN AND METHOD FOR THE PRODUCTION AND USE THEREOF |
WO2018083248A1 (en) | 2016-11-03 | 2018-05-11 | Kymab Limited | Antibodies, combinations comprising antibodies, biomarkers, uses & methods |
CN111954537A (zh) | 2018-04-09 | 2020-11-17 | 美国安进公司 | 生长分化因子15融合蛋白 |
US11197910B1 (en) * | 2020-08-19 | 2021-12-14 | Vitruviae LLC | Fusion proteins for the diagnosis, prophylaxis and treatment of infectious diseases |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6309853B1 (en) * | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
US5541087A (en) * | 1994-09-14 | 1996-07-30 | Fuji Immunopharmaceuticals Corporation | Expression and export technology of proteins as immunofusins |
AU5539596A (en) * | 1995-04-06 | 1996-10-23 | Amylin Pharmaceuticals, Inc. | Anti-obesity agents |
GB9511935D0 (en) * | 1995-06-13 | 1995-08-09 | Smithkline Beecham Plc | Novel compound |
-
2000
- 2000-01-07 SK SK943-2001A patent/SK9432001A3/sk unknown
- 2000-01-07 CZ CZ20012406A patent/CZ20012406A3/cs unknown
- 2000-01-07 CN CN00804274A patent/CN1341121A/zh active Pending
- 2000-01-07 AU AU26025/00A patent/AU778939B2/en not_active Ceased
- 2000-01-07 KR KR1020017008580A patent/KR20020007287A/ko not_active Application Discontinuation
- 2000-01-07 JP JP2000592323A patent/JP2002534962A/ja not_active Withdrawn
- 2000-01-07 ID IDW00200101488A patent/ID30327A/id unknown
- 2000-01-07 BR BR0007414-4A patent/BR0007414A/pt not_active IP Right Cessation
- 2000-01-07 MX MXPA01006922A patent/MXPA01006922A/es unknown
- 2000-01-07 EP EP00904239A patent/EP1141013A2/en not_active Withdrawn
- 2000-01-07 HU HU0105090A patent/HUP0105090A2/hu unknown
- 2000-01-07 WO PCT/US2000/000352 patent/WO2000040615A2/en not_active Application Discontinuation
- 2000-01-07 CA CA002356401A patent/CA2356401A1/en not_active Abandoned
-
2001
- 2001-06-28 ZA ZA200105352A patent/ZA200105352B/en unknown
- 2001-07-06 NO NO20013371A patent/NO20013371L/no not_active Application Discontinuation
-
2003
- 2003-04-18 US US10/419,058 patent/US20040053366A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000040615A2 (en) | 2000-07-13 |
US20040053366A1 (en) | 2004-03-18 |
SK9432001A3 (en) | 2003-02-04 |
WO2000040615A3 (en) | 2000-11-23 |
HUP0105090A2 (hu) | 2002-04-29 |
CN1341121A (zh) | 2002-03-20 |
ZA200105352B (en) | 2002-06-28 |
CA2356401A1 (en) | 2000-07-13 |
KR20020007287A (ko) | 2002-01-26 |
BR0007414A (pt) | 2001-10-16 |
MXPA01006922A (es) | 2002-04-24 |
NO20013371D0 (no) | 2001-07-06 |
JP2002534962A (ja) | 2002-10-22 |
CZ20012406A3 (cs) | 2002-03-13 |
ID30327A (id) | 2001-11-22 |
AU2602500A (en) | 2000-07-24 |
EP1141013A2 (en) | 2001-10-10 |
AU778939B2 (en) | 2004-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20013371L (no) | Ekspresjon og eksport av anti-fedmeproteiner som Fc- fusjonsproteiner | |
PL352332A1 (en) | Expression and export of interferon-alpha proteins as fc fusion proteins | |
Moore et al. | EcoFlex: a multifunctional MoClo kit for E. coli synthetic biology | |
Didovyk et al. | Transcriptional regulation with CRISPR-Cas9: principles, advances, and applications | |
Li et al. | C-Brick: a new standard for assembly of biological parts using Cpf1 | |
WO2000011033A3 (en) | Expression and export of angiostatin and endostatin as immunofusins | |
DE69935857D1 (de) | Expression eukarotischer peptide in pflanzenplastiden | |
AU2590901A (en) | Il-17 homologous polypeptides and therapeutic uses thereof | |
Olson et al. | Design, expression, and stability of a diverse protein library based on the human fibronectin type III domain | |
Lauer et al. | Cloning, nucleotide sequence, and engineered expression of Thermus thermophilus DNA ligase, a homolog of Escherichia coli DNA ligase | |
HUP9800329A2 (hu) | Nukleinsavkonstrukciók strukturális gének sejtciklus-függő módon szabályozott expresszálására | |
WO2002040668A3 (de) | Proteine und den proteinen zugrundeliegende dna-sequenzen mit funktion bei entzündungsereignissen | |
IL127297A0 (en) | Spruce budworm antifreeze proteins genes and methods of using same | |
DE69927249D1 (de) | Induzierendes alphavirengen- expressionssystem | |
DK0868435T3 (da) | Höjeffektivt vævsspecifikt forbindelsesindföringssystem ved anvendelse af streptavidin-protein A-fusionsprotein | |
Davis et al. | Generation of cDNA expression libraries enriched for in-frame sequences | |
HUP0304053A2 (hu) | Új expressziós vektorok és azok alkalmazása | |
Wang et al. | Parallel gene cloning and protein production in multiple expression systems | |
Lupo et al. | The reaction center H subunit is not required for high levels of light-harvesting complex 1 in Rhodospirillum rubrum mutants | |
WO2002014369A3 (en) | Human kininogen d5 domain polypeptides and their use | |
Palmer et al. | Large-scale production of palindrome DNA fragments | |
WO2000064488A3 (en) | Somatic transgene immunization and related methods | |
Liao | Protein and cellular engineering with unnatural amino acids | |
Qiu et al. | Chromosomal Looping‐Based Expression Activation System in Yeast | |
Skowron et al. | DNA-FACE™-an Escherichia coli-based DNA amplification-expression technology for automatic assembly of concatemeric ORFs and proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |